Regulation of P2Y1 receptor-mediated signaling by the ectonucleoside triphosphate diphosphohydrolase isozymes NTPDase1 and NTPDase2

被引:31
作者
Alvarado-Castillo, C
Harden, TK
Boyer, JL
机构
[1] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA
[2] Inspire Pharmaceut Inc, Durham, NC USA
关键词
D O I
10.1124/mol.104.006908
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Ectonucleoside triphosphate diphosphohydrolases (NTPDases) control the concentration of released extracellular nucleotides, but the precise physiological roles played by these isozymes in modulation of P2 receptor signaling remain unclear. Activation of the human P2Y(1) receptor was studied in the presence of NTPDase1 or NTPDase2 expressed either in the same cell as the receptor or in P2Y(1) receptor-expressing cells cocultured with NTPDase-expressing cells. Coexpression of NTPDase1 with the P2Y(1) receptor resulted in increases in the EC50 for 2'-methylthioadenosine 5'-diphosphate (2MeSADP; 12-fold), ADP (50-fold), and ATP (10-fold) for activation of phospholipase C. Similar effects were observed when the P2Y(1) receptor and NTPDase1 were expressed on different cells. These results are explained by the capacity of NTPDase1 to hydrolyze both nucleoside triphosphates and diphosphates. NTPDase2 preferentially hydrolyzes nucleoside triphosphates, and the presence of NTPDase2 under either coexpression or coculture conditions did not change the EC50 of 2MeSADP, ADP, or adenosine 5'-O-(2-thiodiphosphate) for activation of the P2Y(1) receptor. However, the EC50 for ATP was 15-fold lower in the presence of NTPDase2 than in cells expressing the P2Y(1) receptor alone. Whereas expression of NTPDase1 decreased basal activity of the P2Y(1) receptor, the presence of the NTPDase2 resulted in P2Y(1) receptor-dependent increases in basal activity. These results suggest that basal activity of the P2Y(1) receptor is maintained by paracrine or autocrine release of receptor agonists and that the biological and/or pharmacological response mediated by P2Y receptors in target tissues is highly dependent on the types of ectonucleotidases expressed in the vicinity of the receptor.
引用
收藏
页码:114 / 122
页数:9
相关论文
共 39 条
  • [21] IMPROVED ASSAY FOR NANOMOLE AMOUNTS OF INORGANIC-PHOSPHATE
    LANZETTA, PA
    ALVAREZ, LJ
    REINACH, PS
    CANDIA, OA
    [J]. ANALYTICAL BIOCHEMISTRY, 1979, 100 (01) : 95 - 97
  • [22] Constitutive release of ATP and evidence for major contribution of ecto-nucleotide pyrophosphatase and nucleoside diphosphokinase to extracellular nucleotide concentrations
    Lazarowski, ER
    Boucher, RC
    Harden, TK
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (40) : 31061 - 31068
  • [23] Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules
    Lazarowski, ER
    Boucher, RC
    Harden, TK
    [J]. MOLECULAR PHARMACOLOGY, 2003, 64 (04) : 785 - 795
  • [24] PHARMACOLOGICAL SELECTIVITY OF THE CLONED HUMAN P-2U-PURINOCEPTOR - POTENT ACTIVATION BY DIADENOSINE TETRAPHOSPHATE
    LAZAROWSKI, ER
    WATT, WC
    STUTTS, MJ
    BOUCHER, RC
    HARDEN, TK
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 (01) : 1619 - 1627
  • [25] The P2Y(1) receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells
    Leon, C
    Hechler, B
    Vial, C
    Leray, C
    Cazenave, JP
    Gachet, C
    [J]. FEBS LETTERS, 1997, 403 (01) : 26 - 30
  • [26] Functional expression of a cDNA encoding a human ecto-ATPase
    Mateo, J
    Harden, TK
    Boyer, JL
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1999, 128 (02) : 396 - 402
  • [27] Cellular release of and response to ATP as key determinants of the set-point of signal transduction pathways
    Ostrom, RS
    Gregorian, C
    Insel, PA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (16) : 11735 - 11739
  • [28] Agonist action of adenosine triphosphates at the human P2Y1 receptor
    Palmer, RK
    Boyer, JL
    Schachter, JB
    Nicholas, RA
    Harden, TK
    [J]. MOLECULAR PHARMACOLOGY, 1998, 54 (06) : 1118 - 1123
  • [29] CLONING AND EXPRESSION OF A HUMAN-P(2U) NUCLEOTIDE RECEPTOR, A TARGET FOR CYSTIC-FIBROSIS PHARMACOTHERAPY
    PARR, CE
    SULLIVAN, DM
    PARADISO, AM
    LAZAROWSKI, ER
    BURCH, LH
    OLSEN, JC
    ERB, L
    WEISMAN, GA
    BOUCHER, RC
    TURNER, JT
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (08) : 3275 - 3279
  • [30] Ralevic V, 1998, PHARMACOL REV, V50, P413